Your browser doesn't support javascript.
loading
APOBEC3B interaction with PRC2 modulates microenvironment to promote HCC progression.
Wang, Duowei; Li, Xianjing; Li, Jiani; Lu, Yuan; Zhao, Sen; Tang, Xinying; Chen, Xin; Li, Jiaying; Zheng, Yan; Li, Shuran; Sun, Rui; Yan, Ming; Yu, Decai; Cao, Guangwen; Yang, Yong.
Afiliação
  • Wang D; Center for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
  • Li X; Center for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
  • Li J; Center for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
  • Lu Y; Center for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
  • Zhao S; Center for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
  • Tang X; Center for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
  • Chen X; Center for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
  • Li J; Center for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
  • Zheng Y; Center for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
  • Li S; Center for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
  • Sun R; Center for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
  • Yan M; Center for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
  • Yu D; Department of General Surgery, The Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
  • Cao G; Department of Epidemiology, Second Military Medical University, Shanghai, China.
  • Yang Y; Center for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
Gut ; 68(10): 1846-1857, 2019 10.
Article em En | MEDLINE | ID: mdl-31154396
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regulação Neoplásica da Expressão Gênica / Antígenos de Histocompatibilidade Menor / Carcinoma Hepatocelular / Citidina Desaminase / Microambiente Tumoral / Neoplasias Hepáticas Experimentais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Gut Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regulação Neoplásica da Expressão Gênica / Antígenos de Histocompatibilidade Menor / Carcinoma Hepatocelular / Citidina Desaminase / Microambiente Tumoral / Neoplasias Hepáticas Experimentais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Gut Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China